×
-0.00212891669089446 -0.00119106792838592 0.00443602464666547 0.00150993650763876 -0.0171344968910314 -0.036829320903711 -0.0302643795661513 -0.0312022283286598
Stockreport

Seres shares drop 7% after news of FDA orphan drug designation for ulcerative colitis therapy [MarketWatch]

SERES THERAPEUTICS (MCRB)  More Company Research Source: MarketWatch
Last seres therapeutics earnings: 11/8 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com
PDF Seres Therapeutics Inc. shares dropped 7.4% in premarket trade on Monday after the company said its microbiome therapy intended for ulcerative colitis received an orphan drug designation from the Food and Drug Administration. The therapy, SER-287, has been studied in a phase 1b trial in patients with mild-to-moderate ulcerative colitis who were failing current therapies, and the FDA reviewed those results in the orphan drug determination, Seres said. SER-287 is a cutting-edge therapy that is taken orally and contains "a consortium of live bacterial spores" to work on the microbiome, or microorganisms like bacteria and viruses in the body. Typically a company's shares rise on an orphan drug designation, which is intended for products that treat a rare disease, and provides various development incentives, including seven years of marketing exclusivity, tax credits and the waiver of some regulatory fees. But Seres shares have dropped before on seemingly-positive results: when the company [Read more]

IMPACT SNAPSHOT EVENT TIME: MCRB
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
MCRB alerts
from News Quantified
Opt-in for
MCRB alerts

from News Quantified
Opt-in for
MCRB alerts

from News Quantified